Resmed RSMDF
NYSE RSMDF
$22.61 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Resmed (RSMDF) Amortization - Intangibles (2009 - 2026)

Resmed's (RSMDF) quarterly Amortization - Intangibles came in at $10.5 million in Q2 2026, down 11.98% on a YoY basis from $11.9 million in Q2 2025, and down 6.65% quarter-over-quarter from $11.2 million in Q1 2026.

Analysis

Resmed (RSMDF) Amortization - Intangibles (2009 - 2026) Analysis & Trends

Resmed (RSMDF) has reported Amortization - Intangibles for 18 consecutive years, with $10.5 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Amortization - Intangibles fell 11.98% year-over-year to $10.5 million; the trailing twelve-month figure through Jun 2026 stood at $45.5 million (changed 0.42% YoY), and the FY2026 full-year result was $45.5 million, changed 0.43% from the prior year.
  • Amortization - Intangibles eased to $10.5 million in Q2 2026 per RSMDF's latest filing, from $11.2 million in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $12.5 million in Q3 2023 and bottomed at $6.4 million in Q2 2022.
  • Historically, Amortization - Intangibles has averaged $10.9 million across 5 years, with a median of $11.3 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Amortization - Intangibles plunged 42.33% in 2022, then surged 93.12% in 2023.
  • Over 5 years, Amortization - Intangibles stood at $9.6 million in 2022, then gained by 21.06% to $11.6 million in 2023, then fell by 4.58% to $11.0 million in 2024, then rose by 6.49% to $11.8 million in 2025, then dropped by 10.75% to $10.5 million in 2026.
  • According to Business Quant data, Amortization - Intangibles over the past three periods registered $10.5 million, $11.2 million, and $11.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 185.05 Bn 179.45 Bn 7.27 Bn
2 Intuitive Surgical 124.43 Bn 119.22 Bn 1.96 Bn
3 Medtronic 118.52 Bn 109.70 Bn 6.34 Bn
4 Stryker 104.55 Bn 101.07 Bn 4.50 Bn
5 Boston Scientific 67.11 Bn 66.57 Bn 3.85 Bn
6 Edwards Lifesciences 49.85 Bn 45.60 Bn 1.35 Bn
7 Alcon 33.97 Bn 32.52 Bn 1.68 Bn
8 Dexcom 32.28 Bn 30.33 Bn 830.00 Mn
9 Steris 21.15 Bn 20.67 Bn 684.20 Mn
10 Resmed 3.54 Bn 2.07 Bn 861.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.50 Mn
Mar 31, 2026 11.25 Mn
Dec 31, 2025 11.76 Mn
Sep 30, 2025 11.96 Mn
Jun 30, 2025 11.93 Mn
Mar 31, 2025 10.90 Mn
Dec 31, 2024 11.05 Mn
Sep 30, 2024 11.40 Mn
Jun 30, 2024 11.26 Mn
Mar 31, 2024 11.20 Mn
Dec 31, 2023 11.58 Mn
Sep 30, 2023 12.48 Mn
Jun 30, 2023 12.32 Mn
Mar 31, 2023 12.19 Mn
Dec 31, 2022 9.56 Mn
Sep 30, 2022 7.95 Mn
Jun 30, 2022 6.38 Mn
Mar 31, 2022 10.98 Mn
Dec 31, 2021 11.23 Mn
Sep 30, 2021 11.06 Mn